---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000232"
form_type: "8-K/A"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2023-01-05T23:59:59+00:00"
generated_at: "2026-06-20T19:33:03.099257+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences discloses CFO Thomas Schaefer compensation: $260K base, 40% bonus target, 50,000 stock options

## Summary
- Base salary $260,000 per annum; target bonus 40% of base salary as per employment letter effective Jan 3, 2023.
- Granted stock options to purchase 50,000 shares vesting over 4 years with 1-year cliff under 2015 Omnibus Plan.
- Severance: 6-month base salary non-CIC; 12-month salary + 100% equity vesting if terminated within 12 months post-change-in-control.
- Employment is at-will; CIC agreement expires on third anniversary of effective date.

## SEC filing metadata
- accession: 0000950170-23-000232
- form_type: 8-K/A
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2023-01-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017023000232/0000950170-23-000232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017023000232/rkda-20230103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000232
- JSON: https://secwatch.observer/filing/0000950170-23-000232.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.